ZYDUSLIFE Zydus Lifesciences Ltd US FDA Inspections Announcement 2024 - FDA Approval Zydus receives tentative approval from USFDA for Azilsartan Medoxomil Tablets, 40 mg and 80 mg with annual sales of USD 89 mn in the United States. The drug will be manufactured in Ahmedabad SEZ - II, India..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Zydus Lifesciences Ltd